Study confirms effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma
Dose-adjusted EPOCH-R is already an option for diffuse large B-cell lymphomas and can be administered in an outpatient setting.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Burkitt Lymphoma | Lymphoma | National Institutes of Health (NIH) | Study | Toxicology